{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:05:26Z","timestamp":1783393526269,"version":"3.54.6"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12035-023-03303-0","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T11:03:42Z","timestamp":1679483022000},"page":"3839-3854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Th17\/IL-17 Axis in HTLV-1-Associated Myelopathy Tropical Spastic Paraparesis and Multiple Sclerosis: Novel Insights into the Immunity During HAMTSP"],"prefix":"10.1007","volume":"60","author":[{"given":"Mohammadreza","family":"Shafiei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-2252","authenticated-orcid":false,"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"3303_CR1","doi-asserted-by":"crossref","unstructured":"Ernzen KJ, Panfil AR (2022) Regulation of HTLV-1 transformation. Biosci Rep 42(3)","DOI":"10.1042\/BSR20211921"},{"key":"3303_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3389\/fmicb.2019.00885","volume":"10","author":"S Nozuma","year":"2019","unstructured":"Nozuma S, Jacobson S (2019) Neuroimmunology of human T-lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol 10:885","journal-title":"Front Microbiol"},{"issue":"5","key":"3303_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.25072","volume":"82","author":"S Azodi","year":"2017","unstructured":"Azodi S, Nair G, Enose-Akahata Y, Charlip E, Vellucci A, Cortese I et al (2017) Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM\/TSP) and multiple sclerosis (MS). Ann Neurol 82(5):719\u2013728","journal-title":"Ann Neurol"},{"issue":"1-2","key":"3303_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.06.045","volume":"262","author":"J Oger","year":"2007","unstructured":"Oger J (2007) HTLV-1 infection and the viral etiology of multiple sclerosis. J Neurol Sci 262(1-2):100\u2013104","journal-title":"J Neurol Sci"},{"key":"3303_CR5","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","volume":"1","author":"CR Bangham","year":"2015","unstructured":"Bangham CR, Araujo A, Yamano Y, Taylor GP (2015) HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Primers 1:15012","journal-title":"Nat Rev Dis Primers"},{"key":"3303_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM (2018) Human T cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol 36:43\u201371","journal-title":"Annu Rev Immunol"},{"key":"3303_CR7","doi-asserted-by":"crossref","unstructured":"Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H (2018) Cytokine networks dysregulation during HTLV-1 infection and associated diseases. Viruses 10(12)","DOI":"10.3390\/v10120691"},{"issue":"2","key":"3303_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0036-1579739","volume":"36","author":"M Sospedra","year":"2016","unstructured":"Sospedra M, Martin R (2016) Immunology of multiple sclerosis. Semin Neurol 36(2):115\u2013127","journal-title":"Semin Neurol"},{"key":"3303_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821\u2013852","journal-title":"Annu Rev Immunol"},{"key":"3303_CR10","doi-asserted-by":"publisher","first-page":"986789","DOI":"10.1155\/2013\/986789","volume":"2013","author":"SK Bedoya","year":"2013","unstructured":"Bedoya SK, Lam B, Lau K, Larkin J 3rd. (2013) Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013:986789","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"3303_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Takeuchi Y, Hirota K (2019) The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol 41(3):283\u2013297","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3303_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M et al (1995) HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1(1):50\u201361","journal-title":"J Neurovirol"},{"issue":"1","key":"3303_CR13","first-page":"12","volume":"16","author":"H Hofstetter","year":"2009","unstructured":"Hofstetter H, Gold R, Hartung HP (2009) Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 16(1):12\u201318","journal-title":"Int MS J"},{"issue":"5","key":"3303_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman A, Hauptmann J, Regen T (2015) The role of IL-17 in CNS diseases. Acta Neuropathol 129(5):625\u2013637","journal-title":"Acta Neuropathol"},{"key":"3303_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","volume":"69","author":"E Beurel","year":"2018","unstructured":"Beurel E, Lowell JA (2018) Th17 cells in depression. Brain Behav Immun 69:28\u201334","journal-title":"Brain Behav Immun"},{"key":"3303_CR16","doi-asserted-by":"crossref","unstructured":"Maciak K, Pietrasik S, Dziedzic A, Redlicka J, Saluk-Bijak J, Bijak M et al (2021) Th17-related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s disease) and multiple sclerosis-a review. Int J Mol Sci 22(16)","DOI":"10.3390\/ijms22168946"},{"key":"3303_CR17","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012:925135","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"3303_CR18","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348\u20132357","journal-title":"J Immunol"},{"issue":"6","key":"3303_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jdi.13541","volume":"12","author":"YC Chang","year":"2021","unstructured":"Chang YC, Hee SW, Chuang LM (2021) T helper 17 cells: a new actor on the stage of type 2 diabetes and aging? J Diabetes Investig 12(6):909\u2013913","journal-title":"J Diabetes Investig"},{"issue":"12","key":"3303_CR20","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD et al (2012) Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61(12):1693\u20131700","journal-title":"Gut"},{"key":"3303_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-immunol-101819-092536","volume":"39","author":"S Majumder","year":"2021","unstructured":"Majumder S, McGeachy MJ (2021) IL-17 in the pathogenesis of disease: good intentions gone awry. Annu Rev Immunol 39:537\u2013556","journal-title":"Annu Rev Immunol"},{"key":"3303_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","volume":"87","author":"R Stadhouders","year":"2018","unstructured":"Stadhouders R, Lubberts E, Hendriks RW (2018) A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun 87:1\u201315","journal-title":"J Autoimmun"},{"issue":"22","key":"3303_CR23","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1073\/pnas.1415675112","volume":"112","author":"SN Harbour","year":"2015","unstructured":"Harbour SN, Maynard CL, Zindl CL, Schoeb TR, Weaver CT (2015) Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci USA 112(22):7061\u20137066","journal-title":"Proc Natl Acad Sci USA"},{"key":"3303_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fimmu.2018.01112","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Tian J, Wang S (2018) Insight into non-pathogenic Th17 cells in autoimmune diseases. Front Immunol 9:1112","journal-title":"Front Immunol"},{"issue":"6","key":"3303_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.coi.2011.08.007","volume":"23","author":"A Peters","year":"2011","unstructured":"Peters A, Lee Y, Kuchroo VK (2011) The many faces of Th17 cells. Curr Opin Immunol. 23(6):702\u2013706","journal-title":"Curr Opin Immunol."},{"key":"3303_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fimmu.2017.00698","volume":"8","author":"R Volchenkov","year":"2017","unstructured":"Volchenkov R, Nygaard V, Sener Z, Skalhegg BS (2017) Th17 Polarization under hypoxia results in increased IL-10 production in a pathogen-independent manner. Front Immunol 8:698","journal-title":"Front Immunol"},{"issue":"3","key":"3303_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134(3):392\u2013404","journal-title":"Cell"},{"key":"3303_CR28","doi-asserted-by":"crossref","unstructured":"Zhang S (2018) The role of transforming growth factor beta in T helper 17 differentiation. Immunology 155(1):24\u201335","DOI":"10.1111\/imm.12938"},{"key":"3303_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485\u2013517","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"3303_CR30","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T (2010) IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 40(7):1830\u20131835","journal-title":"Eur J Immunol"},{"issue":"9","key":"3303_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8(9):967\u2013974","journal-title":"Nat Immunol"},{"key":"3303_CR32","doi-asserted-by":"publisher","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","volume":"80","author":"B Wu","year":"2020","unstructured":"Wu B, Wan Y (2020) Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol 80:106187","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3303_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","volume":"33","author":"PP Ahern","year":"2010","unstructured":"Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ et al (2010) Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33(2):279\u2013288","journal-title":"Immunity"},{"key":"3303_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"LA Tesmer","year":"2008","unstructured":"Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87\u2013113","journal-title":"Immunol Rev"},{"issue":"12","key":"3303_CR35","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T et al (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8(12):1390\u20131397","journal-title":"Nat Immunol"},{"issue":"10","key":"3303_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A et al (2012) Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13(10):991\u2013999","journal-title":"Nat Immunol"},{"key":"3303_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2014.12.007","volume":"46","author":"PW Lee","year":"2015","unstructured":"Lee PW, Yang Y, Racke MK, Lovett-Racke AE (2015) Analysis of TGF-beta1 and TGF-beta3 as regulators of encephalitogenic Th17 cells: implications for multiple sclerosis. Brain Behav Immun 46:44\u201349","journal-title":"Brain Behav Immun"},{"issue":"7318","key":"3303_CR38","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467(7318):967\u2013971","journal-title":"Nature"},{"key":"3303_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.msard.2017.09.003","volume":"18","author":"YF Li","year":"2017","unstructured":"Li YF, Zhang SX, Ma XW, Xue YL, Gao C, Li XY (2017) Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 18:20\u201325","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"3303_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2353\/ajpath.2006.051225","volume":"169","author":"Y Miyatake","year":"2006","unstructured":"Miyatake Y, Ikeda H, Ishizu A, Baba T, Ichihashi T, Suzuki A et al (2006) Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1. Am J Pathol 169(1):189\u2013199","journal-title":"Am J Pathol"},{"issue":"24","key":"3303_CR41","doi-asserted-by":"publisher","first-page":"21092","DOI":"10.1074\/jbc.M110.200907","volume":"286","author":"A Refaat","year":"2011","unstructured":"Refaat A, Zhou Y, Suzuki S, Takasaki I, Koizumi K, Yamaoka S et al (2011) Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9. J Biol Chem 286(24):21092\u201321099","journal-title":"J Biol Chem"},{"issue":"2-3","key":"3303_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","volume":"97","author":"N Nishimoto","year":"1990","unstructured":"Nishimoto N, Yoshizaki K, Eiraku N, Machigashira K, Tagoh H, Ogata A et al (1990) Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurol Sci 97(2-3):183\u2013193","journal-title":"J Neurol Sci"},{"issue":"2","key":"3303_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0000000000001576","volume":"77","author":"C Brites","year":"2018","unstructured":"Brites C, Abrahao M, Bozza P, Netto EM, Lyra A, Bahia F (2018) Infection by HTLV-1 is associated with high levels of proinflammatory cytokines in HIV-HCV-coinfected patients. J Acquir Immune Defic Syndr 77(2):230\u2013234","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3303_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","volume":"57","author":"T Aranami","year":"2008","unstructured":"Aranami T, Yamamura T (2008) Th17 Cells and autoimmune encephalomyelitis (EAE\/MS). Allergol Int 57(2):115\u2013120","journal-title":"Allergol Int"},{"key":"3303_CR45","doi-asserted-by":"crossref","unstructured":"Hiltensperger M, Korn T (2018) The interleukin (IL)-23\/T helper (Th)17 axis in experimental autoimmune encephalomyelitis and multiple sclerosis. Cold Spring Harb Perspect Med 8(1)","DOI":"10.1101\/cshperspect.a029637"},{"issue":"2","key":"3303_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1615\/CritRevImmunol.2016017387","volume":"36","author":"AY Mah","year":"2016","unstructured":"Mah AY, Cooper MA (2016) Metabolic regulation of natural killer Cell IFN-gamma production. Crit Rev Immunol 36(2):131\u2013147","journal-title":"Crit Rev Immunol"},{"key":"3303_CR47","doi-asserted-by":"crossref","unstructured":"Alspach E, Lussier DM, Schreiber RD (2019) Interferon gamma and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harb Perspect Biol 11(3)","DOI":"10.1101\/cshperspect.a028480"},{"issue":"2","key":"3303_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","volume":"135","author":"C Tang","year":"2012","unstructured":"Tang C, Chen S, Qian H, Huang W (2012) Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 135(2):112\u2013124","journal-title":"Immunology"},{"key":"3303_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R (2015) Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol 6:492","journal-title":"Front Immunol"},{"issue":"10","key":"3303_CR50","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1002\/eji.201444612","volume":"44","author":"LS Dungan","year":"2014","unstructured":"Dungan LS, McGuinness NC, Boon L, Lynch MA, Mills KH (2014) Innate IFN-gamma promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages. Eur J Immunol 44(10):2903\u20132917","journal-title":"Eur J Immunol"},{"key":"3303_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3303_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.21037\/tp-21-565","volume":"11","author":"DM Zu","year":"2022","unstructured":"Zu DM, Zhang L (2022) Assessment of mechanisms of infectious pneumonia based on expression of fibrinogen, procalcitonin, high-sensitivity C-reactive protein expression, T helper 17 cells, regulatory T cells interleukin-10, and interleukin-17. Transl Pediatr 11(1):73\u201384","journal-title":"Transl Pediatr"},{"issue":"4-5","key":"3303_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1359-6101(02)00025-4","volume":"13","author":"AM Beebe","year":"2002","unstructured":"Beebe AM, Cua DJ, de Waal MR (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4-5):403\u2013412","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"3303_CR54","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/eji.201444960","volume":"45","author":"DY Vogel","year":"2015","unstructured":"Vogel DY, Kooij G, Heijnen PD, Breur M, Peferoen LA, van der Valk P et al (2015) GM-CSF promotes migration of human monocytes across the blood brain barrier. Eur J Immunol 45(6):1808\u20131819","journal-title":"Eur J Immunol"},{"issue":"1","key":"3303_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bpa.12097","volume":"24","author":"A Uzawa","year":"2014","unstructured":"Uzawa A, Mori M, Kuwabara S (2014) Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications. Brain Pathol 24(1):67\u201373","journal-title":"Brain Pathol"},{"key":"3303_CR56","unstructured":"Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF (1993) HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kB with other transcription factor families. Oncogene 8(12):3189\u20133197"},{"issue":"12","key":"3303_CR57","doi-asserted-by":"publisher","first-page":"e28432","DOI":"10.1371\/journal.pone.0028432","volume":"6","author":"L Zhang","year":"2011","unstructured":"Zhang L, Yuan S, Cheng G, Guo B (2011) Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6(12):e28432","journal-title":"PLoS One"},{"issue":"12","key":"3303_CR58","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ni1537","volume":"8","author":"JS Stumhofer","year":"2007","unstructured":"Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA et al (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8(12):1363\u20131371","journal-title":"Nat Immunol"},{"issue":"5","key":"3303_CR59","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1182\/blood.V84.5.1573.1573","volume":"84","author":"I Yamashita","year":"1994","unstructured":"Yamashita I, Katamine S, Moriuchi R, Nakamura Y, Miyamoto T, Eguchi K et al (1994) Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood 84(5):1573\u20131578","journal-title":"Blood"},{"issue":"7","key":"3303_CR60","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","volume":"12","author":"M Chabaud","year":"2000","unstructured":"Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12(7):1092\u20131099","journal-title":"Cytokine"},{"issue":"Pt 7","key":"3303_CR61","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1099\/vir.0.79921-0","volume":"85","author":"MD Dodon","year":"2004","unstructured":"Dodon MD, Li Z, Hamaia S, Gazzolo L (2004) Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells. J Gen Virol 85(Pt 7):1921\u20131932","journal-title":"J Gen Virol"},{"issue":"1","key":"3303_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jcv.2013.05.006","volume":"58","author":"S Sarkis","year":"2013","unstructured":"Sarkis S, Belrose G, Peloponese JM Jr, Olindo S, Cesaire R, Mesnard JM et al (2013) Increased osteopontin expression in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patient cells is associated with IL-17 expression. J Clin Virol 58(1):295\u2013298","journal-title":"J Clin Virol"},{"issue":"7","key":"3303_CR63","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ijc.31922","volume":"144","author":"K Subramanian","year":"2019","unstructured":"Subramanian K, Dierckx T, Khouri R, Menezes SM, Kagdi H, Taylor GP et al (2019) Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma\/leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy? Int J Cancer 144(7):1664\u20131675","journal-title":"Int J Cancer"},{"issue":"2","key":"3303_CR64","doi-asserted-by":"publisher","first-page":"e2028","DOI":"10.1371\/journal.pntd.0002028","volume":"7","author":"FE Leal","year":"2013","unstructured":"Leal FE, Ndhlovu LC, Hasenkrug AM, Bruno FR, Carvalho KI, Wynn-Williams H et al (2013) Expansion in CD39(+) CD4(+) immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis 7(2):e2028","journal-title":"PLoS Negl Trop Dis"},{"key":"3303_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tube.2017.10.004","volume":"108","author":"NB Carvalho","year":"2018","unstructured":"Carvalho NB, de Lourdes BM, Souza AS, Netto EM, Arruda S, Santos SB et al (2018) Impaired TNF, IL-1beta, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. Tuberculosis (Edinb) 108:35\u201340","journal-title":"Tuberculosis (Edinb)"},{"issue":"4","key":"3303_CR66","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1089\/vim.2016.0152","volume":"30","author":"H Neco","year":"2017","unstructured":"Neco H, Teixeira VGS, Trindade ACL, Magalhaes PMR, Lorena VMB, Vasconcelos LR et al (2017) IL17A polymorphism is not associated with human T-lymphotropic virus 1-associated myelopathy\/tropical spastic paraparesis. Viral Immunol 30(4):298\u2013301","journal-title":"Viral Immunol"},{"issue":"8","key":"3303_CR67","doi-asserted-by":"publisher","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","volume":"4","author":"Y Yamano","year":"2009","unstructured":"Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D et al (2009) Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One 4(8):e6517","journal-title":"PLoS One"},{"issue":"10","key":"3303_CR68","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.ppat.1002270","volume":"7","author":"NK Seich Al Basatena","year":"2011","unstructured":"Seich Al Basatena NK, Macnamara A, Vine AM, Thio CL, Astemborski J, Usuku K et al (2011) KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog. 7(10):e1002270","journal-title":"PLoS Pathog."},{"issue":"7","key":"3303_CR69","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J et al (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96(7):3848\u20133853","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"3303_CR70","doi-asserted-by":"publisher","first-page":"e26229","DOI":"10.1371\/journal.pone.0026229","volume":"6","author":"JL Espinoza","year":"2011","unstructured":"Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H et al (2011) A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6(10):e26229","journal-title":"PLoS One"},{"issue":"4","key":"3303_CR71","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/rheumatology\/ken512","volume":"48","author":"GB Nordang","year":"2009","unstructured":"Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Forre OT, Helgetveit K et al (2009) Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) 48(4):367\u2013370","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3303_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.humimm.2014.12.011","volume":"76","author":"J Liu","year":"2015","unstructured":"Liu J, Xu Q, Yuan Q, Wang Z, Xing C, Yuan Y (2015) Association of IL-17A and IL-17F polymorphisms with gastric cancer risk in Asians: a meta-analysis. Hum Immunol 76(1):6\u201312","journal-title":"Hum Immunol"},{"issue":"4","key":"3303_CR73","doi-asserted-by":"publisher","first-page":"e0174869","DOI":"10.1371\/journal.pone.0174869","volume":"12","author":"JA Domingos","year":"2017","unstructured":"Domingos JA, Soares LS, Bandeira LM, Bonin CM, Vicente AC, Zanella L et al (2017) Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil. PLoS One 12(4):e0174869","journal-title":"PLoS One"},{"issue":"11","key":"3303_CR74","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/jmv.23341","volume":"84","author":"SB Santos","year":"2012","unstructured":"Santos SB, Oliveira P, Luna T, Souza A, Nascimento M, Siqueira I et al (2012) Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection. J Med Virol 84(11):1809\u20131817","journal-title":"J Med Virol"},{"issue":"3","key":"3303_CR75","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1086\/649871","volume":"50","author":"GP Garlet","year":"2010","unstructured":"Garlet GP, Giozza SP, Silveira EM, Claudino M, Santos SB, Avila-Campos MJ et al (2010) Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to a standard periodontopathogen infection. Clin Infect Dis 50(3):e11\u2013e18","journal-title":"Clin Infect Dis"},{"key":"3303_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.immunol.14.1.207","volume":"14","author":"D Kagi","year":"1996","unstructured":"Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H (1996) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14:207\u2013232","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"3303_CR77","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","volume":"99","author":"PK Goon","year":"2002","unstructured":"Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP et al (2002) High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. Blood 99(9):3335\u20133341","journal-title":"Blood"},{"issue":"1","key":"3303_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.1993.tb00719.x","volume":"3","author":"Y Iwasaki","year":"1993","unstructured":"Iwasaki Y (1993) Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathol 3(1):1\u201310","journal-title":"Brain Pathol"},{"issue":"3","key":"3303_CR79","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood.V98.3.721","volume":"98","author":"E Hanon","year":"2001","unstructured":"Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN et al (2001) High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 98(3):721\u2013726","journal-title":"Blood"},{"issue":"8","key":"3303_CR80","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/v3081374","volume":"3","author":"C Journo","year":"2011","unstructured":"Journo C, Mahieux R (2011) HTLV-1 and innate immunity. Viruses 3(8):1374\u20131394","journal-title":"Viruses"},{"key":"3303_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41\u2013101","journal-title":"Adv Immunol"},{"issue":"2","key":"3303_CR82","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","volume":"180","author":"K Hieshima","year":"2008","unstructured":"Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O (2008) Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol 180(2):931\u2013939","journal-title":"J Immunol"},{"key":"3303_CR83","doi-asserted-by":"crossref","unstructured":"Yoshie O (2021) CCR4 as a therapeutic target for cancer immunotherapy. Cancers (Basel) 13(21)","DOI":"10.3390\/cancers13215542"},{"issue":"6175","key":"3303_CR84","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/333776a0","volume":"333","author":"K Leung","year":"1988","unstructured":"Leung K, Nabel GJ (1988) HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 333(6175):776\u2013778","journal-title":"Nature"},{"key":"3303_CR85","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fimmu.2017.00727","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao H, Bo C, Kang Y, Li H (2017) What else can CD39 tell us? Front Immunol 8:727","journal-title":"Front Immunol"},{"issue":"1","key":"3303_CR86","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/s41598-019-38897-w","volume":"9","author":"N Alvarez-Sanchez","year":"2019","unstructured":"Alvarez-Sanchez N, Cruz-Chamorro I, Diaz-Sanchez M, Lardone PJ, Guerrero JM, Carrillo-Vico A (2019) Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients. Sci Rep 9(1):2302","journal-title":"Sci Rep"},{"issue":"5","key":"3303_CR87","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW et al (2005) Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115(5):1361\u20131368","journal-title":"J Clin Invest"},{"issue":"1","key":"3303_CR88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4049\/jimmunol.0903846","volume":"185","author":"F Toulza","year":"2010","unstructured":"Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP et al (2010) Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol 185(1):183\u2013189","journal-title":"J Immunol"},{"issue":"3","key":"3303_CR89","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1349-7006.2008.01054.x","volume":"100","author":"Y Shimizu","year":"2009","unstructured":"Shimizu Y, Takamori A, Utsunomiya A, Kurimura M, Yamano Y, Hishizawa M et al (2009) Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages. Cancer Sci 100(3):481\u2013489","journal-title":"Cancer Sci"},{"issue":"1","key":"3303_CR90","doi-asserted-by":"publisher","first-page":"e1055444","DOI":"10.1080\/2162402X.2015.1055444","volume":"5","author":"M Thibaudin","year":"2016","unstructured":"Thibaudin M, Chaix M, Boidot R, Vegran F, Derangere V, Limagne E et al (2016) Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology 5(1):e1055444","journal-title":"Oncoimmunology"},{"issue":"2","key":"3303_CR91","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.yexcr.2017.09.030","volume":"360","author":"C Lang","year":"2017","unstructured":"Lang C, Wang J, Chen L (2017) CD25-expressing Th17 cells mediate CD8(+) T cell suppression in CTLA-4 dependent mechanisms in pancreatic ductal adenocarcinoma. Exp Cell Res 360(2):384\u2013389","journal-title":"Exp Cell Res"},{"issue":"6924","key":"3303_CR92","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744\u2013748","journal-title":"Nature"},{"issue":"Pt 12","key":"3303_CR93","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awp289","volume":"132","author":"V Brucklacher-Waldert","year":"2009","unstructured":"Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E (2009) Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132(Pt 12):3329\u20133341","journal-title":"Brain"},{"issue":"10","key":"3303_CR94","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","volume":"19","author":"T Moser","year":"2020","unstructured":"Moser T, Akgun K, Proschmann U, Sellner J, Ziemssen T (2020) The role of TH17 cells in multiple sclerosis: therapeutic implications. Autoimmun Rev 19(10):102647","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3303_CR95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11481-019-09852-3","volume":"15","author":"M Melnikov","year":"2020","unstructured":"Melnikov M, Rogovskii V, Boyksmall o CA, Pashenkov M (2020) Dopaminergic therapeutics in multiple sclerosis: focus on Th17-cell functions. J Neuroimmune Pharmacol 15(1):37\u201347","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"3303_CR96","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ana.21748","volume":"66","author":"H Kebir","year":"2009","unstructured":"Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N et al (2009) Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol 66(3):390\u2013402","journal-title":"Ann Neurol"},{"issue":"5","key":"3303_CR97","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/brain\/awy069","volume":"141","author":"J van Langelaar","year":"2018","unstructured":"van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA et al (2018) T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain 141(5):1334\u20131349","journal-title":"Brain"},{"issue":"4-5","key":"3303_CR98","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12026-019-09089-5","volume":"67","author":"G Ntolkeras","year":"2019","unstructured":"Ntolkeras G, Barba C, Mavropoulos A, Vasileiadis GK, Dardiotis E, Sakkas LI et al (2019) On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells. Immunol Res 67(4-5):310\u2013324","journal-title":"Immunol Res"},{"issue":"Pt A","key":"3303_CR99","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2014.03.009","volume":"262","author":"C Sie","year":"2014","unstructured":"Sie C, Korn T, Mitsdoerffer M (2014) Th17 cells in central nervous system autoimmunity. Exp Neurol 262(Pt A):18\u201327","journal-title":"Exp Neurol"},{"issue":"9","key":"3303_CR100","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","volume":"190","author":"R Duhen","year":"2013","unstructured":"Duhen R, Glatigny S, Arbelaez CA, Blair TC, Oukka M, Bettelli E (2013) Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet. J Immunol 190(9):4478\u20134482","journal-title":"J Immunol"},{"issue":"3","key":"3303_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.1993","volume":"12","author":"K Hirota","year":"2011","unstructured":"Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ et al (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12(3):255\u2013263","journal-title":"Nat Immunol"},{"key":"3303_CR102","doi-asserted-by":"publisher","first-page":"932265","DOI":"10.3389\/fimmu.2022.932265","volume":"13","author":"A Belpaire","year":"2022","unstructured":"Belpaire A, van Geel N, Speeckaert R (2022) From IL-17 to IFN-gamma in inflammatory skin disorders: is transdifferentiation a potential treatment target? Front Immunol 13:932265","journal-title":"Front Immunol"},{"issue":"20","key":"3303_CR103","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-14-0572","volume":"20","author":"K Tsukasaki","year":"2014","unstructured":"Tsukasaki K, Tobinai K (2014) Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer Res 20(20):5217\u20135225","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3303_CR104","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/infdis\/jiu438","volume":"211","author":"J Yamauchi","year":"2015","unstructured":"Yamauchi J, Coler-Reilly A, Sato T, Araya N, Yagishita N, Ando H et al (2015) Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy. J Infect Dis 211(2):238\u2013248","journal-title":"J Infect Dis"},{"issue":"10","key":"3303_CR105","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR (2008) High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111(10):5047\u20135053","journal-title":"Blood"},{"key":"3303_CR106","doi-asserted-by":"crossref","unstructured":"Lee GR (2018) The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci 19(3)","DOI":"10.3390\/ijms19030730"},{"issue":"1","key":"3303_CR107","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15(1):23","journal-title":"Cell Commun Signal"},{"issue":"11","key":"3303_CR108","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1086\/503874","volume":"193","author":"U Oh","year":"2006","unstructured":"Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S (2006) Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J Infect Dis 193(11):1557\u20131566","journal-title":"J Infect Dis"},{"issue":"1","key":"3303_CR109","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","volume":"14","author":"KM Danikowski","year":"2017","unstructured":"Danikowski KM, Jayaraman S, Prabhakar BS (2017) Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation 14(1):117","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3303_CR110","first-page":"352","volume":"57","author":"I Lazibat","year":"2018","unstructured":"Lazibat I, Rubinic Majdak M, Zupanic S (2018) Multiple sclerosis: new aspects of immunopathogenesis. Acta Clin Croat 57(2):352\u2013361","journal-title":"Acta Clin Croat"},{"issue":"9","key":"3303_CR111","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav 5(9):e00362","journal-title":"Brain Behav"},{"issue":"3","key":"3303_CR112","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QCO.0b013e3282f88b48","volume":"21","author":"T Holmoy","year":"2008","unstructured":"Holmoy T, Hestvik AL (2008) Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr Opin Infect Dis 21(3):271\u2013278","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"3303_CR113","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","volume":"61","author":"JR Orland","year":"2003","unstructured":"Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C et al (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61(11):1588\u20131594","journal-title":"Neurology"},{"issue":"3","key":"3303_CR114","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s004019900170","volume":"100","author":"MM Aye","year":"2000","unstructured":"Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y et al (2000) Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol 100(3):245\u2013252","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3303_CR115","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","volume":"96","author":"Y Iwasaki","year":"1990","unstructured":"Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP). J Neurol Sci 96(1):103\u2013123","journal-title":"J Neurol Sci"},{"issue":"9","key":"3303_CR116","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/jnnp.56.9.1004","volume":"56","author":"A Yoshioka","year":"1993","unstructured":"Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K (1993) Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 56(9):1004\u20131007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3303_CR117","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jnnp.2008.167155","volume":"9","author":"SA Cooper","year":"2009","unstructured":"Cooper SA, van der Loeff MS, Taylor GP (2009) The neurology of HTLV-1 infection. Pract Neurol 9(1):16\u201326","journal-title":"Pract Neurol"},{"issue":"1","key":"3303_CR118","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clim.2011.03.004","volume":"142","author":"M Comabella","year":"2012","unstructured":"Comabella M, Khoury SJ (2012) Immunopathogenesis of multiple sclerosis. Clin Immunol 142(1):2\u20138","journal-title":"Clin Immunol"},{"issue":"6","key":"3303_CR119","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0306-9877(93)90111-3","volume":"41","author":"S Ijichi","year":"1993","unstructured":"Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M et al (1993) An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM\/TSP. Med Hypotheses 41(6):542\u2013547","journal-title":"Med Hypotheses"},{"issue":"4","key":"3303_CR120","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K et al (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52(4):424\u2013430","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3303_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-2005-917668","volume":"25","author":"P Grindstaff","year":"2005","unstructured":"Grindstaff P, Gruener G (2005) The peripheral nervous system complications of HTLV-1 myelopathy (HAM\/TSP) syndromes. Semin Neurol 25(3):315\u2013327","journal-title":"Semin Neurol"},{"issue":"11","key":"3303_CR122","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D et al (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117(11):3113\u20133122","journal-title":"Blood"},{"issue":"5","key":"3303_CR123","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s004150050363","volume":"246","author":"M Abe","year":"1999","unstructured":"Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M (1999) Activation of macrophages\/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol 246(5):358\u2013364","journal-title":"J Neurol"},{"issue":"Suppl 2","key":"3303_CR124","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1086\/344269","volume":"186","author":"S Jacobson","year":"2002","unstructured":"Jacobson S (2002) Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186(Suppl 2):S187\u2013S192","journal-title":"J Infect Dis"},{"key":"3303_CR125","doi-asserted-by":"publisher","first-page":"614940","DOI":"10.3389\/fmicb.2020.614940","volume":"11","author":"S Aghajanian","year":"2020","unstructured":"Aghajanian S, Teymoori-Rad M, Molaverdi G, Mozhgani SH (2020) Immunopathogenesis and cellular interactions in human T-cell leukemia virus type 1 associated myelopathy\/tropical spastic paraparesis. Front Microbiol 11:614940","journal-title":"Front Microbiol"},{"issue":"3","key":"3303_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nri.2016.144","volume":"17","author":"T Korn","year":"2017","unstructured":"Korn T, Kallies A (2017) T cell responses in the central nervous system. Nat Rev Immunol 17(3):179\u2013194","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"3303_CR127","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.humimm.2020.02.009","volume":"81","author":"R Balasa","year":"2020","unstructured":"Balasa R, Barcutean L, Balasa A, Motataianu A, Roman-Filip C, Manu D (2020) The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis. Hum Immunol 81(5):237\u2013243","journal-title":"Hum Immunol"},{"issue":"11","key":"3303_CR128","doi-asserted-by":"publisher","first-page":"e1000205","DOI":"10.1371\/journal.ppat.1000205","volume":"4","author":"PV Afonso","year":"2008","unstructured":"Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P et al (2008) Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog 4(11):e1000205","journal-title":"PLoS Pathog"},{"issue":"1","key":"3303_CR129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0022-510X(89)90043-9","volume":"90","author":"N Tsukada","year":"1989","unstructured":"Tsukada N, Tanaka Y, Yanagisawa N (1989) Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type I associated myelopathy and other demyelinating disorders. J Neurol Sci 90(1):33\u201342","journal-title":"J Neurol Sci"},{"issue":"1-2","key":"3303_CR130","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0165-5728(02)00100-5","volume":"127","author":"M Ikegami","year":"2002","unstructured":"Ikegami M, Umehara F, Ikegami N, Maekawa R, Osame M (2002) Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy. J Neuroimmunol 127(1-2):134\u2013138","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3303_CR131","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.4049\/jimmunol.179.4.2576","volume":"179","author":"PV Afonso","year":"2007","unstructured":"Afonso PV, Ozden S, Prevost MC, Schmitt C, Seilhean D, Weksler B et al (2007) Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 179(4):2576\u20132583","journal-title":"J Immunol"},{"issue":"16","key":"3303_CR132","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1128\/JVI.00539-16","volume":"90","author":"C Curis","year":"2016","unstructured":"Curis C, Percher F, Jeannin P, Montange T, Chevalier SA, Seilhean D et al (2016) Human T-lymphotropic virus type 1-induced overexpression of activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of infected lymphocytes through the blood-brain barrier. J Virol 90(16):7303\u20137312","journal-title":"J Virol"},{"issue":"4","key":"3303_CR133","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1096\/fj.09-141978","volume":"24","author":"J Huppert","year":"2010","unstructured":"Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E et al (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24(4):1023\u20131034","journal-title":"FASEB J"},{"key":"3303_CR134","doi-asserted-by":"publisher","first-page":"590409","DOI":"10.1155\/2014\/590409","volume":"2014","author":"DW Wojkowska","year":"2014","unstructured":"Wojkowska DW, Szpakowski P, Ksiazek-Winiarek D, Leszczynski M, Glabinski A (2014) Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediators Inflamm 2014:590409","journal-title":"Mediators Inflamm"},{"issue":"6","key":"3303_CR135","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.4049\/jimmunol.181.6.3750","volume":"181","author":"RA O\u2019Connor","year":"2008","unstructured":"O\u2019Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC et al (2008) Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 181(6):3750\u20133754","journal-title":"J Immunol"},{"issue":"2","key":"3303_CR136","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/intimm\/14.2.147","volume":"14","author":"Y Imaizumi","year":"2002","unstructured":"Imaizumi Y, Sugita S, Yamamoto K, Imanishi D, Kohno T, Tomonaga M et al (2002) Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha\/CCL20 gene transcription via the NF-kappa B pathway. Int Immunol 14(2):147\u2013155","journal-title":"Int Immunol"},{"issue":"23","key":"3303_CR137","doi-asserted-by":"publisher","first-page":"14893","DOI":"10.1074\/jbc.272.23.14893","volume":"272","author":"M Baba","year":"1997","unstructured":"Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K et al (1997) Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 272(23):14893\u201314898","journal-title":"J Biol Chem"},{"issue":"5","key":"3303_CR138","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S et al (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10(5):514\u2013523","journal-title":"Nat Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03303-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T14:31:11Z","timestamp":1685197871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03303-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":138,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3303"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03303-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the authors give their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}